| Sesamol-loaded PLGA nanosuspension for accelerating wound healing in diabetic foot ulcer in rats K Gourishetti, R Keni, PG Nayak, SR Jitta, NA Bhaskaran, L Kumar, ... International Journal of Nanomedicine, 9265-9282, 2020 | 53 | 2020 |
| An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation N Ajitkumar Bhaskaran, L Kumar, MS Reddy, G PAI K Acta Pharmaceutica 71 (1), 57-79, 2021 | 39 | 2021 |
| Use of social media for seeking health related information–an exploratory study N Bhaskaran, M Kumar, MD Janodia Journal of Young Pharmacists 9 (2), 267, 2017 | 35 | 2017 |
| Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems NA Bhaskaran, L Kumar Journal of Controlled Release 336, 16-39, 2021 | 26 | 2021 |
| Lamotrigine lipid nanoparticles for effective treatment of epilepsy: a focus on brain targeting via nasal route PK Gangurde, N Ajitkumar B, L Kumar Journal of Pharmaceutical Innovation 14, 91-111, 2019 | 26 | 2019 |
| Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: preparation, in-vitro and in-vivo evaluations NA Bhaskaran, SR Jitta, SP Cheruku, N Kumar, L Kumar International Journal of Biological Macromolecules 211, 301-315, 2022 | 22 | 2022 |
| Anti-oxidant Containing Nanostructured Lipid Carriers of Ritonavir: Development, Optimization, and In Vitro and In Vivo Evaluations SR Jitta, NA Bhaskaran, Salwa, L Kumar AAPS PharmSciTech 23 (4), 88, 2022 | 10 | 2022 |
| Development of cream to enhance the antifungal activity and reduce the side effects of fluconazole for the treatment of Candida albicans NA Bhaskaran, Salwa, AV Fernandes, G Volfová, CR Pydi, L Kumar, ... Tenside Surfactants Detergents 59 (3), 231-239, 2022 | 9 | 2022 |
| Pellets and techniques of pelletization K Manoharan, NA Bhaskaran, L Kumar Research Journal of Pharmacy and Technology 12 (12), 6157-6164, 2019 | 9 | 2019 |
| Analytical method development using central composite design for estimation of lamotrigine in lipid nanoformulation PK Gangurde, NA Bhaskaran, R Verma, J Jose, L Kumar Tablet 8 (4), 2020 | 7 | 2020 |
| Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS SR Jitta, Salwa, NA Bhaskaran, SM Marques, L Kumar Expert Opinion on Drug Delivery 19 (9), 1133-1148, 2022 | 6 | 2022 |
| Development and validation of RP-HPLC method for quantification of total, free and entrapped ritonavir in lipid nanocarriers and drug content of film coated fixed dose formulation SR Jitta, NA Bhaskaran, L Kumar, RK Shirodkar Indian Journal of Pharmaceutical Education and Research 56 (3s), s547-s558, 2022 | 5 | 2022 |
| Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer NA Bhaskaran, SR Jitta, L Kumar, P Sharma, OP Kulkarni, G Hari, ... International Journal of Biological Macromolecules 253, 127142, 2023 | 4 | 2023 |
| Enhanced tissue distribution of ritonavir-loaded nanostructured lipid carriers—recommending its dose reduction SR Jitta, Salwa, NA Bhaskaran, SM Marques, L Kumar, SP Cheruku, ... Drug Delivery and Translational Research 14 (1), 116-130, 2024 | 1 | 2024 |
| Nose-to-Brain delivery of antiretroviral drug loaded lipidic nanocarriers to purge HIV reservoirs in CNS: A safer approach S Mehrotra, PK Bg, NA Bhaskaran, JS Reddy, L Kumar Journal of Drug Delivery Science and Technology, 104833, 2023 | | 2023 |
| Solid lipid nanoparticles based drug delivery for targeting brain tumors NA Bhaskaran, L Kumar Nanocarriers for Drug-Targeting Brain Tumors, 237-268, 2022 | | 2022 |
| Nanopharmacokinetics, pharmacodynamics (PK/PD), and clinical relationship NA Bhaskaran, NT Chevala, L Kumar Nanomedicines for Breast Cancer Theranostics, 245-268, 2020 | | 2020 |
| A REVIEW ON THE APPLICATION OF NANOTECHNOLOGY IN THE TREATMENT OF HYPERTENSION VK Tippavajhala Journal of Global Pharma Technology, 2017 | | 2017 |
| Polymeric nanoparticles for the co delivery of irinotecan and quercetin facilitated by surface modifiers for targeting colon cancer NA Bhaskaran Manipal, 0 | | |
